Resveratrol bioconversion by fungi is a fascinating area of research, as they possess a wide range of enzymes that can metabolize various organic compounds such as stilbenoids and convert them into valuable products. In vitro antifungal assays have demonstrated different activity levels of grape stilbenoids - such as viniferins - against Pyricularia oryzae, Plasmopara viticola and Botrytis cinerea. These compounds can be synthesized or extracted from different natural sources or raw materials, however, the potential of fungal whole cells as a tool to provide biologically active dimers of resveratrol has been poorly investigated. In this study, the ability of Botrytis cinerea and Cryphonectria parasitica to convert resveratrol into dimers was investigated in liquid cultures. Both fungal species grew in broths amended with resveratrol, but their morphology was affected in the presence of resveratrol dissolved in DMSO. Reverse-phase HPLC analysis confirmed that B. cinerea produces delta-viniferin, epsilon-viniferin and pallidol, and with this study, we report for the first time the same ability also for C. parasitica hypovirulent strain. The stilbenoid production dynamics revealed that B. cinerea quickly converted resveratrol into dimers that are not detectable 24 hours later in nutrient-rich medium. On the contrary, C. parasitica required more time than B. cinerea to convert resveratrol, but the dimers could be detected even after 48 hours. These data open the perspective to use C. parasitica hypovirulent strains for the sustainable and zero-waste production of bioactive molecules to be used for plant protection.

Resveratrol bioconversion into dimeric stilbenoids using fungal biofactories / D. Bulgari, M. Corti, A. Kunova, F. Annunziata, G. Peron, S. Dall’Acqua, C. Pizzatti, M. Saracchi, M. Pasquali, S. Dallavalle, A. Pinto, P. Cortesi. - In: JOURNAL OF PLANT PATHOLOGY. - ISSN 2239-7264. - 107:4(2025 Nov), pp. 1595-1596. ( 30. Congress of the Italian Phytopathological Society (SIPaV) : September, 15 - 17 Catania 2025).

Resveratrol bioconversion into dimeric stilbenoids using fungal biofactories

D. Bulgari
Primo
;
M. Corti
Secondo
;
A. Kunova;F. Annunziata;C. Pizzatti;M. Saracchi;M. Pasquali;S. Dallavalle;A. Pinto
Penultimo
;
P. Cortesi
Ultimo
2025

Abstract

Resveratrol bioconversion by fungi is a fascinating area of research, as they possess a wide range of enzymes that can metabolize various organic compounds such as stilbenoids and convert them into valuable products. In vitro antifungal assays have demonstrated different activity levels of grape stilbenoids - such as viniferins - against Pyricularia oryzae, Plasmopara viticola and Botrytis cinerea. These compounds can be synthesized or extracted from different natural sources or raw materials, however, the potential of fungal whole cells as a tool to provide biologically active dimers of resveratrol has been poorly investigated. In this study, the ability of Botrytis cinerea and Cryphonectria parasitica to convert resveratrol into dimers was investigated in liquid cultures. Both fungal species grew in broths amended with resveratrol, but their morphology was affected in the presence of resveratrol dissolved in DMSO. Reverse-phase HPLC analysis confirmed that B. cinerea produces delta-viniferin, epsilon-viniferin and pallidol, and with this study, we report for the first time the same ability also for C. parasitica hypovirulent strain. The stilbenoid production dynamics revealed that B. cinerea quickly converted resveratrol into dimers that are not detectable 24 hours later in nutrient-rich medium. On the contrary, C. parasitica required more time than B. cinerea to convert resveratrol, but the dimers could be detected even after 48 hours. These data open the perspective to use C. parasitica hypovirulent strains for the sustainable and zero-waste production of bioactive molecules to be used for plant protection.
Settore AGRI-05/B - Patologia vegetale
nov-2025
Società Italiana di Patologia Vegetale
Article (author)
File in questo prodotto:
File Dimensione Formato  
s42161-025-02022-w-1_Bulgari_ Resveratrol bioconversion_p1595.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Licenza: Nessuna licenza
Dimensione 520.45 kB
Formato Adobe PDF
520.45 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
2025_Bulgari_SIPAV.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Licenza: Creative commons
Dimensione 351.36 kB
Formato Adobe PDF
351.36 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1225318
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact